Greater effect of diabetes on LDL size in women than in men

Diabetes Care

Volumn 17, Issue 10, 1994, Pages 1164-1171

  Haffner, Steven M ^a   Mykkänen, Leena ^a   Stern, Michael P ^a   Paidi, Michael ^b   Howard, Barbara V ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Medlantic Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; GEMFIBROZIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; ORANGEDEX; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; POPULATION RISK; POSTMENOPAUSE; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE;

EID: 0028101782     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.17.10.1164     Document Type: Article

References (37)

1. Stamler J, Vaccaro O, Neaton JD, Went-worth D, Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors and 12-year mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
2. Assman G, Schulte H: The Prospective Cardiovascular Munster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116:1713-1724, 1988
3. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up. Diabetes 23:105-111, 1974
4. Falko JM, Parr JH, Simpson RN, Wynn V: Lipoprotein analyses in varying degrees of glucose tolerance and control populations. Am J Med 83:641-647, 1987
5. Laakso M, Barrett-Connor E: Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 9:665-772, 1993
6. Grouse JR, Parks JS, Schey HM, Kahl FR: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985
7. Austin MA, Breslow JL, Hennekens CHD, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921, 1988
8. Campos H, Genest JJ, Blijlevens E, Mc-Namara JR, Jenner JE, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis 12:187-195, 1992
9. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990
10. McNamara JR, Campos H, Ordovas JM, Peterson RM, Wilson PWF, Schaefer EJ: Effect of gender, age and lipid status on low density subfraction distribution: results of the Framingham Offspring Study. Arteriosclerosis 7:483-490, 1987
11. Swinkels DW, Demacker PNM, Hendricks JCM, Van't Laar A: Low density lipoprotein subfractions and relationship of other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9:604-613, 1989
12. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 85:381-387, 1993
13. Campos H, Willett WC, Peterson RM, Siles X, Bailey SM, Wilson PWF, Posner BM, Ordovas JM, Schaefer EJ: Nutrient intake comparisons between Framingham and urban Costa Rica: associations with lipids, lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb 11:1089-1099, 1991
14. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM: Insulin resistance in individuals with small, dense lipoprotein particles. J Clin Invest 92:141-146, 1993
15. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV: LDL size and subclass pattern in a biethnic population. Arteriosclerosis 13:1623-1630, 1993
16. Feingold KR, Grunfeld C, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Arterioscler Thromb 12:1496-1502, 1992
17. Barrett-Connor E, Wingard DL: Sex difference in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 118:489-496, 1983
18. Jarrett RJ, McCarthy P, Keen H: The Bed-ford Study: ten year mortality rates in newly diagnosed diabetics, boderline diabetics, and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
19. Head J, Fuller JH: International variation in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33:477-481, 1990
20. Kleinman JC, Donahue R, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988
21. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 311:953-959, 1984
22. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
23. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 315:220-224, 1986
24. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M, Franco LJ: A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol 123:96-112, 1996
25. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP: Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14:102-108, 1991
26. World Health Organization Expert Committee: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985 (Tech. Rep. Ser. no. 727)
27. 27: Haffner SM, Stern MP, Hazuda HP, Patterson JK, Malina R: Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes 10: 493-502, 1986
28. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
29. Wilkinson C: SYSTAT: The System for Statistics. Evanston, IL, SYSTAT, Inc., 1985, p. 457-598
30. Dallai GE: Logistic: a logistic regression package for the IBM PC. Am Stat 42:31, 1988
31. Camejo G, Hurt-Camejo E, Bondjers G: Effect of proteoglycans on lipoprotein-cell interactions: possible contribution to atherogenesis. Curr Opin Lipidol 1:431-436, 1990
32. de Graaf J, Haklemmens HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
33. Tribble DL, Hull LG, Wood PD, Krauss RM: Variations in oxidative susceptibility among six low density lipoprotein subfractions of different density and particle size. Atherosclerosis 93:189-194, 1992
34. Criqui MH, Heiss GH, Cohn R: Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220-1225, 1993
35. American Diabetes Association: Detection and management of lipid disorders. Diabetes Care 16:828-834, 1993
36. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetes Care 13: 153-169, 1990
37. Lahdenpera S, Tily-Kiesi M, Vuorinen-Morkkola H, Kuusi T, Taskinen MR: Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 16:584-592, 1993